スポンサーリンク
横浜市立大学 第2内科 | 論文
- ICDの適応拡大とその問題点--予後改善とQOL改善の狭間 (特集 新しい展開 どう治すか? 不整脈治療)
- 徐脈性不整脈へのペースメーカ療法 (特集 不整脈非薬物療法の現況と5年後の展望)
- 心房ペーシングと植込み型心房細動除細動器
- Atrioventricular (AV) delay の 至適化
- 埋込み型ペースメーカーの開発と今後の課題
- Bedside Teaching CRTと心筋逆リモデリング
- Association of gene polymorphism of the fat-mass and obesity-associated gene with insulin resistance in Japanese
- The Japanese Society of Hypertension Committee for Guidelines for the Management of Hypertension
- NEDD4L protein truncating variant (v13[G/A] : rs4149601) is associated with essential hypertension in a sample of the Japanese population
- Accumulation of common polymorphisms is associated with development of hypertension : a 12-year follow-up from the Ohasama study
- A randomized, double-blind, four-arm parallel-group study of the efficacy and safety of azelnidipine and olmesartan medoxomil combination therapy compared with each monotherapy in Japanese patients with essential hypertension : the REZALT study
- Risk of Smoking and Metabolic Syndrome for Incidence of Cardiovascular Disease : Comparison of Relative Contribution in Urban Japanese Population : The Suita Study
- Prevention of osteoporosis by angiotensin-converting enzyme inhibitor in spontaneous hypertensive rats
- A Promoter Polymorphism of Lamin A/C Gene is an Independent Genetic Predisposition to Arterial Stiffness in a Japanese General Population (The Tanno and Sobetsu Study)
- Genetic basis of hypertension for the development of tailored medicine
- Association of SLC6A9 Gene Variants with Human Essential Hypertension
- Effects of candesartan and amlodipine on cardiovascular events in hypertensive patients with chronic kidney disease : subanalysis of the CASE-J Study
- Effect of chronic kidney disease on individual and population medical expenditures in the Japanese population
- Identification of Genetic Markers Associated With High-Density Lipoprotein-Cholesterol by Genome-Wide Screening in a Japanese Population : The Suita Study
- Effects of Cardiac Complications on Cardiovascular Events in Japanese High-Risk Hypertensive Patients : Subanalysis of the CASE-J Trial